These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32102917)

  • 21. Suppression of Cholangiocarcinoma Cell Growth and Proliferation by Atractylodes lancea (Thunb) DC. through ERK-Signaling Cascade.
    Martviset P; Panrit L; Chantree P; Muhamad P; Na-Bangchang K
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3633-3640. PubMed ID: 34837922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
    Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAIL Enhances Shikonin Induced Apoptosis through ROS/JNK Signaling in Cholangiocarcinoma Cells.
    Zhou G; Yang Z; Wang X; Tao R; Zhou Y
    Cell Physiol Biochem; 2017; 42(3):1073-1086. PubMed ID: 28662515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.
    Bui KC; Nguyen TML; Barat S; Scholta T; Xing J; Bhuria V; Sipos B; Wilkens L; Nguyen LT; Le HS; Velavan TP; Bozko P; Plentz RR
    Curr Med Chem; 2024; 31(28):4534-4548. PubMed ID: 38361349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Wang Y; Yu H; Xie X; Deng T; Ye L; Wu L; Ding X; Yang Z; Zhu Q; Li J; Zheng Y; Yu Z; Chen G
    Oncogene; 2021 Jun; 40(25):4324-4337. PubMed ID: 34079085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo.
    Yapasert R; Lertprasertsuk N; Subhawa S; Poofery J; Sripanidkulchai B; Banjerdpongchai R
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticancer effects of Resina Draconis extract on cholangiocarcinoma.
    Wen F; Zhao X; Zhao Y; Lu Z; Guo Q
    Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
    Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
    Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
    Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
    Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
    Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
    Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma
    Sungwan P; Kidoikhammouan S; Thonsri U; Saengboonmee C; Wongkham S; Okada S; Seubwai W
    In Vivo; 2024; 38(5):2284-2293. PubMed ID: 39187317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma.
    Wang X; Zhou X; Zhang L; Zhang X; Yang C; Piao Y; Zhao J; Jin L; Jin G; An R; Ren X
    Chin Med; 2022 Jun; 17(1):69. PubMed ID: 35698073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
    Saikawa S; Kaji K; Nishimura N; Seki K; Sato S; Nakanishi K; Kitagawa K; Kawaratani H; Kitade M; Moriya K; Namisaki T; Mitoro A; Yoshiji H
    Cancer Lett; 2018 Oct; 434():120-129. PubMed ID: 30031758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A; Akiyama Y; Sripa B; Yuasa Y
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.